Meticulous Research®, a premier global market research firm, has released its latest report titled, “Africa IVD Market Size, Share, Forecast & Trends Analysis by Offering, Technology (Immunoassay, PoC, Molecular Diagnostics, Coagulation), Application (Infectious Diseases, Diabetes, Oncology), Diagnostic Approach (Lab, OTC, PoCT), End User - Forecast to 2031.”

The report projects that the Africa in vitro diagnostics (IVD) market will reach $1.65 billion by 2031, growing at a CAGR of 3.1% from 2024 to 2031. This growth is driven by several factors, including:

Increasing prevalence of chronic and infectious diseases.
Significant investments from IVD market players in Africa.
Rising demand for Point-of-Care (POC) and rapid diagnostic solutions.
Growing geriatric population.
Government initiatives enhancing healthcare infrastructure.
Increased healthcare expenditure and R&D investments.
Download Sample Report Here : https://www.meticulousresearch.com/download-sample-report/cp_id=5415
Despite these opportunities, the market faces challenges such as high costs associated with advanced IVD products, variability in rapid test results, and stringent regulatory requirements for high and moderate-complexity tests.

Emerging Opportunities

The report highlights the growing awareness of early diagnosis, advancements in genomics and proteomics, and the rising adoption of personalized medicine as potential growth drivers for market stakeholders. However, uneven healthcare access and a shortage of trained professionals remain significant hurdles.

Check complete table of contents with list of table and figures: https://www.meticulousresearch.com/product/africa-ivd-market-5415

Key Players in the Africa IVD Market

Leading companies in the Africa IVD market include:

Abbott Laboratories (U.S.)
Becton, Dickinson and Company (U.S.)
bioMérieux SA (France)
Danaher Corporation (U.S.)
F. Hoffmann-La Roche Ltd (Switzerland)
QIAGEN N.V. (Netherlands)
Siemens Healthineers AG (Germany)
Thermo Fisher Scientific Inc. (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
Illumina, Inc. (U.S.)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China)
Market Insights and Future Outlook

The report segments the Africa IVD market by offering (reagents & kits, instruments, and software & services), technology (including immunoassay, molecular diagnostics, and others), application (focusing on infectious diseases, diabetes, oncology, etc.), diagnostic approach (laboratory testing, point-of-care testing, and OTC/self-testing), and end user (diagnostic laboratories, hospitals, home healthcare, etc.).

Reagents & Kits Segment: Expected to register the highest CAGR of 3.3% during the forecast period, driven by the increasing incidence of infectious diseases and rising test volumes.
Immunoassay Technologies: Anticipated to dominate with a 34.5% market share in 2024, favored for their efficiency and accuracy in diagnosing prevalent diseases like HIV and malaria.
Infectious Diseases Application: Projected to hold the largest market share due to the high prevalence of diseases such as COVID-19 and malaria.
Quick Buy : https://www.meticulousresearch.com/Checkout/47708335
Geographical Insights

The report provides an extensive analysis of key markets, including South Africa, Nigeria, Egypt, and more. Notably, South Africa is expected to exhibit the highest growth rate of 8.3% during the forecast period, fueled by increasing healthcare investments and improved access to diagnostic services.

Key Questions Addressed in the Report

What is the current revenue generated by IVD products in Africa?
What growth rate is expected for IVD product demand over the next 5-7 years?
What are the major factors impacting the Africa IVD market?
Which segments are experiencing significant traction?
What are the key geographical trends and opportunities?
For a deeper dive into these insights and more, access the full report : https://www.meticulousresearch.com/request-sample-report/cp_id=5415

Contact Information

For more details, please contact:

Meticulous Research®
Email: [email protected]
Sales Contact: +1-646-781-8004
Connect with us on LinkedIn.